Skip to main content
Header image
User picture
Academic title: RNDr.
Phone: +420 585 632 138
Groups: IMTM, LEM, POSTDOCTORAL FELLOW, STAFF

Postdoctoral training

Status: Ongoing.

About me

I am a researcher specializing in the field of nuclear medicine and pharmacy, with a primary research focus on the preparation and analysis of radiolabeled compounds for advanced imaging techniques such as microPET, SPECT, MRI, and CT. I am doing biodistribution studies of radiolabeled compounds in vivo and investigating the behaviour of these compounds in vitro. Before my work in nuclear medicine and pharmacy, I had a background in molecular toxicology and pharmacology. I concentrated on elucidating transcriptional regulatory mechanisms related to drug metabolism and the processing of environmental pollutants.

Journals

ŠPIČÁKOVÁ, A., B. SZOTAKOVA, D. DIMUNOVA, Z. MYSLIVECKOVA, V. KUBICEK, M. AMBROZ, K. LNĚNIČKOVÁ, K. KRASULOVÁ, P. ANZENBACHER, L. SKALOVA
Nerolidol and Farnesol Inhibit Some Cytochrome P450 Activities but Did Not Affect Other Xenobiotic-Metabolizing Enzymes in Rat and Human Hepatic Subcellular Fractions. Molecules. 2017, 22(4), pii: E509, ISSN: 1420-3049, PMID: 28338641,  PDF.
STEPANKOVA, M., K. KRASULOVÁ, A. DORCICAKOVA, O. KURKA, P. ANZENBACHER, Z. DVORAK
Optical isomers of dihydropyridine calcium channel blockers display enantiospecific effects on the expression and enzyme activities of human xenobiotics-metabolizing cytochromes P450. Toxicology Letters. 2016, 16(262), 173-186, ISSN: 0378-4274, PMID: 27732883,
KOPECNA ZAPLETALOVA, M., K. KRASULOVÁ, P. ANZENBACHER, J. HODEK, E. ANZENBACHEROVÁ
Interaction of isoflavonoids with human liver microsomal cytochromes P450: inhibition of CYP enzyme activities. Xenobiotica. 2016, 47(4), 324-331, ISSN: 0049-8254, PMID: 27312150,